Although biomarkers such as oligoclonal bands, immunoglobin G (IgG) index, and aquaporin-4 (AQP-4) are currently used to assess MS activity and treatment response, no key biomarkers like α-synuclein in PD or Aβ in AD have been established for MS [70]. Here, AQP4 is linked to Parkinson disease.